MedPath
HSA Approval

PALAVO SUSPENSION 120MG/5ML

SIN17213P

PALAVO SUSPENSION 120MG/5ML

PALAVO SUSPENSION 120MG/5ML

April 2, 2025

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

N02BE01

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (M) SDN BHD

Active Ingredients

PARACETAMOL

120MG/5ML

Acetaminophen

Documents

Patient Information Leaflets

Patient information leaflet.pdf

Approved: April 2, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PALAVO SUSPENSION 120MG/5ML - HSA Approval | MedPath